The Food and Drug Administration instructs US consumers on asking for labeling requirements and other regulatory actions on potential allergens in food, including dietary supplements, in a draft guidance explaining its authority to regulate allergens not specifically identified as major food allergens.
A draft guidance published on 18 April asks for comments on a guidance which, when finalized, will outline the FDA’s thinking on the approach it generally intends to take in...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?